1. Interna Szczeklika. Podręcznik chorób wewnętrznych. Medycyna Praktyczna. Warszawa 2015.

2. Kostowski W, Herman Z. FARMAKOLOGIA – podstawy farmakoterapii. Tom 1-2. Wydawnictwo Lekarskie PZWL. Warszawa 2004.

3. „Rekomendacje postępowania w pozaszpitalnych zakażeniach układu oddechowego 2010”. Narodowy Program Ochrony Antybiotyków.

4. O`Brien K, Dowell S, Schwartz B. et al. Cough illness bronchitis. Pediatrics 1998;101(Suppl.):S178-81.

5. Garofalo R, Hintz K, Hill V, et al. A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus. J Med Virol 2005;75:282-9.

6. Paradowska-Stankiewicz I. Zakład Epidemiologii, Narodowy Instytut Zdrowia Publicznego – PZH, http://szczepienia. pzh.gov.pl/main.php?p=3&id=80&sz=229&to, wersja z 02.20.2015 r.

7. UNICEF. Committing to Child Survival: A Promise Renewed. Progress Report 2015. Available at: http://www.apromiserenewed. org/wp-content/uploads/2015/09/APR_2015_8_Sep_15. pdf. Wersja z dnia 27.12.2015 r.

8. http://worldpneumoniaday.org/wp-content/uploads/2014/11/Final- WPD-2014-Fact-Sheet1.pdf Wersja z dnia 27.12.2015 r.

9. Iroh Tam PY, Bernstein E, Ma X. Blood Culture in Evaluation of Pediatric Community-Acquired Pneumonia. A Systematic Review and Meta-analysis. Hosp Pediatr. 2015 Jun;5(6):324-36.

10. Williams DJ, Edwards KM, Self WH. Antibiotic Choice for Children Hospitalized With Pneumonia and Adherence to National Guidelines. Pediatrics. 2015 Jul;136(1):44-52.

11. Dubos F, Delvart C, Mordacq C. Evaluation of ambulatory prescribing for community-acquired pneumonia in children. Arch Pediatr. 2014 Aug;21(8):827-33.

12. Saleh EA, Schroeder DR, Hanson AC. Guideline-concordant antibiotic prescribing for pediatric outpatients with otitis media, community-acquired pneumonia, and skin and soft tissue infections in a large multispecialty healthcare system. Clin Res Infect Dis. 2015 Jan 10;2(1).

13. Murtagh, Kurowski E, Shah SS, Thomson J. Improvement methodology increases guideline recommended blood cultures in children with pneumonia. Pediatrics. 2015 Apr;135(4):e1052-9.

14. GINA Report, Global Strategy for Asthma Management and Prevention, updated April 2015.

15. Pocket Guide for Asthma Management and Prevention in Children 5 Years and Younger, updated April 2015.

16. Vestbo J, Hurd SS, Agustí AG. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65.

17. Fonseca W, Hoppu K, Rey LC. Comparing pharmacokinetics of amoxicillin given twice or three times per day to children older than 3 months with pneumonia. Antimicrob Agents Chemother. 2003 Mar;47(3):997-1001.

18. Agarwal G, Awasthi S, Kabra SK. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ. 2004 Apr 3;328(7443):791

19. Pilishvili T, Bennett NM. Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines. Vaccine. 2015 Nov 27;33 Suppl 4:D60-5.

20. Davis S, Feikin D, Johnson HL. The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review BMC Public Health. 2013;13 Suppl 3:S21.

21. Conklin L, Loo JD, Kirk J. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine- type invasive pneumococcal disease among young children. Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S109-18.